The state of prostate cancer treatment: advances in approach for advanced disease

The state of prostate cancer treatment: advances in approach for advanced disease

In this online, self-learning activity: Prostate cancer (PC) is the most common form of malignancy among men in the United States. There are over 299,000 new cases and over 35,000 deaths from PC in the U.S. annually. Over the past few decades, the death rates associated with PC have declined, likely due to changes in screening practices and improved treatment options. However, during the same time period, the incidence of advanced PC has increased, and it accounts for about half of patients who are diagnosed. While patients with local or regional disease have 5-year survival rates close to 100%, that number decreases to under 35% for patients with metastatic disease (mPC).

  • Provider:ScientiaCME
  • Activity Link: https://www.scientiacme.org/cme-539-111-0-1-11-prostate-cancer-treatment-cme
  • Start Date: 2024-11-02 05:00:00
  • End Date: 2024-11-02 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
  • MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
  • Commercial Support: Source: Merck - Amount: 24568.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: Medical Oncology
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments

Warning: file_put_contents(/nas/content/live/sleepliteracy/wp-content/uploads/wpdiscuz/cache/comments/.htaccess): Failed to open stream: Permission denied in /nas/content/live/sleepliteracy/wp-content/plugins/wpdiscuz/utils/class.WpdiscuzCache.php on line 161
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.